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The primary structure of rat chromogranin A has been deduced from a rat adrenal cDNA clone. A comparison of rat 
and bovine chromogranin A reveals several similar features: clusters of polyglutamic acid, similar amino acid composi- 
tion, position of seven of 10 pairs of basic ammo acids, identical placement of the only two cysteine residues, a highly 
conserved N- and C-terminus, and a sequence homologous to porcine pancreastatin 149 [(1986) Nature 324, 4764781. 
Unique features of rat chromogranin A are an eicosaglutamine s quence and two potential N-linked glycosylation sites. 
Chromogranin A mRNA is detectable in adrenal medulla, anterior pituitary, cerebral cortex, and hippocampus, as well 
as tumor cell lines derived from pancreas, pituitary, and adrenal medulla. 
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1. INTRODUCTION 
Chromogranin A, an acidic glycoprotein [2,3], 
was the first-discovered constituent of adreno- 
medullary chromaffin granules 14-61. This protein 
has been found in many endocrine and neural 
tissues [7-111. Recently, the primary structure of 
bovine chromogranin A was determined [12,131. It 
is a 431-amino-acid protein with an apparent 
molecular mass of 75 kDa and an actual molecular 
mass of 48 kDa. Several structural features of 
bovine chromogranin A have been oted: it con- 
tains regions of homology to two calcium-binding 
proteins, clusters of polyglutamic acid, an RGD se- 
quence [13] which in fibronectin subserves attach- 
ment to the cell surface [14], eight dibasic amino 
acid residues which may be sites of specific pro- 
teolytic processing, and potential phosphorylation 
sites [12,13,15,16]. The biological actions of 
chromogranin A remain unknown, partly due to 
lack of structural information about chromogra- 
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nin A in rat, the most widely studied and accessible 
animal model for endocrine function. Here, we 
describe the cloning and primary sequence of rat 
prechromogranin A, compare it to the bovine se- 
quence, and describe the distribution of its mRNA 
in rat endocrine tumors and tissues. 
2. MATERIALS AND METHODS 
2.1. Isolation of rat chromogranin A cDNA clones 
A cDNA library of rat adrenal mRNA was constructed in 
pcDV1 vector according to Okayama and Berg [17]. The library 
contains 1 x 10’ recombinant transformants. Approx. 2 x 10’ 
transformants were screened by colony hybridization with a 
“P-labeled RNA probe mixture. Four complementary RNA 
probes to different portions of the bovine chromogranin A 
mRNA coding region were generated by in vitro transcription 
of linearized pGem plasmid containing fragments of the cDNA, 
pCHRG4A [17]. The probe hybridized to three clones. The 
longest clone, pCHRG12B, was determined to be incomplete in 
length by restriction and sequence analysis. The library was 
plated again and hybridized with a nick-translated 995 bp PstI 
fragment of pCHRGl2B. Ten positive clones were obtained 
after screening 5 x lo5 colonies. The clone pCHRG2H was 
determined to be the longest. Overlapping fragments of the 
cDNA were isolated, subcloned into M 13, and sequenced by the 
method of Sanger. 
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Fig.1. DNA sequencing strategy of pCHRG2H and 
pCHRG12B. Restriction map of cDNA shows sites used to 
subclone fragments into Ml3 for sequencing. Solid arrows 
below map indicate the direction and extent of sequencing. 
2.2. Northern blot analysis 
Total RNAs were extracted from tissues and cell lines with 
phenol after digestion with proteinase K or guanidinium 
hydrochloride. RNAs were denatured and electrophoresed on 
1% agarose gel containing 2.2 M formaldehyde. Following 
electrophoresis, the RNAs were stained with ethidium bromide, 
transferred onto GeneScreen (NEN) and baked for 2 h at 80°C. 
The Northern blot was pre-hybridized at 45°C for 24 h, then 
hybridized at 45’C for 20 h with a nick-translated 995 bp PstI 
fragment of pCHRG2H. The blot was washed in 0.2 X SSC 
(1 x SSC = 150 mM NaCI/ 15 mM sodium citrate)/O. 1% SDS 
at 55”C, then autoradiographed for 12-48 h at -70°C with 
DuPont Lightning Plus intensifying screens. 
2.3. In situ hybridization histochemistry 
Tissue preparation, hybridization, and autoradiography were 
performed according to Siegel and Young [18]. 35S-labeled 
messenger and complementary RNA probes were produced by 
in vitro transcription of linearized pGEM plasmid containing 
995 bp PstI fragment of pCHRG12B. 
3. RESULTS AND DISCUSSION 
A rat prechromogranin A cDNA was obtained 
from a rat adrenal clone bank probed with the 
bovine cDNA, pCHRG4A [12]. The rat clone, 
pCHRG2H, is 1871 nucleotides in length, and en- 
codes a protein of 466 amino acids (fig.2). A 
hydrophobic signal sequence of 18 amino acids is 
83% homologous to the corresponding bovine 
signal peptide (fig.3). The actual molecular mass 
of rat chromogranin A deduced from this sequence 
is 50.2 kDa. The apparent molecular mass of rat 
chromogranin A on SDS-PAGE is 86 kDa [19]. 
Rat chromogranin A is therefore similar to the 
bovine protein in its anomalous behavior upon 
denaturing gel electrophoresis [12,13]. The greatest 
homology between rat and bovine chromogranins 
lies in the N-terminal 76, and the C-terminal 108 
amino acids (86 and 89% homology, respectively). 
Only two cysteines are found in rat chromogranin 
A; they are positioned 20 amino acids apart in the 
N-terminus, exactly as in the bovine sequence. 
Benedum et al. [20] have noted a similarly placed 
pair of cysteines in the sequence of human 
chromogranin B (secretogranin I), an acidic 
sulfated glycoprotein co-stored with chromogranin 
A in adrenomedullary chromaffin granules. Rat 
chromogranin A contains 10 pairs of basic amino 
acid residues, which are potential signals for pro- 
teolytic processing of hormone precursors [ 12,131. 
Seven of these are similarly positioned in the 
bovine protein, and six of the invariant pairs are 
clustered at the C-terminus. In rat and bovine 
chromogranin A, a peptide designated WE-14 
(fig.3) is flanked by pairs of basic amino acids, and 
is identical in both proteins except for a single con- 
servative amino acid substitution (K for R) at the 
third position (fig.2). The sequence of this peptide 
is probably highly conserved in human, cow, rat, 
chicken, frog, sheep, and fish, since specific 
WE-14 immunoreactivity is found in chromaffin 
tissue of these species (Rieker, S. et al., unpub- 
lished). We suggest that the strong sequence con- 
servation at the N-terminus of chromogranin A 
may be related to its intracellular role, including 
targeting to secretory vesicles, while sequence con- 
servation at the C-terminus may be due to the 
presence of biologically active peptides for which 
chromogranin A is a prohormone. A prohormone 
function for chromogranin A is suggested by the 
homology to pancreastatin, a 49-amino acid 
polypeptide isolated from porcine pancreas and 
reported to inhibit insulin and somatostatin secre- 
tion from pancreas at nanomolar concentrations 
[l]. Porcine pancreastatin is 71% homologous to 
bovine chromogranin A 25 l-294 (prechromogran- 
in A 269-3 12). This region of rat chromogranin A 
(residues 264-3 14; fig.2) possesses equal 
homology with the corresponding bovine sequence 
and porcine pancreastatin (59%). The homology 
between porcine pancreastatin 33-49, the region in 
which all the biological activity of the molecule 
resides, and the corresponding regions of bovine 
and rat chromogranins A is 76%. The C-terminal 
GK dipeptide which would be required for pro- 
teolytic cleavage and amidation is conserved in rat. 
However, the rat and bovine sequences differ N- 
terminally adjacent to the pancreastatin-like 
region. Identification of the cleavage sites of this 
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1 CACCACCATC ACCGCCACTG CCACCACCAC CGCTACCGCA GTGCTCCCAC TGGTGCAGAG CTCCAGTGGT CACAGACCCA CTTCCGCCAT CCTCCTGCAG CAGCTCGCCC 110 
111 TCTCTTTCCG CACCGTCCGG CTCGCT ATGCGCTCCTCCGCGGCTTTGGCGCTTCTGCTGTGCGCCGGGCAAGTCTTTGCCCTTCCTGTGAACAGCCCTATGAC~AGGGGACACT 226 
MRSSAALALLLCAGQVFALPVNSPMTKGDT 12 
-18 -1 
227 AAGGTGATGAAGTGTGTCCTGGAGGTCATCTCCGACTCGCTGTCCAAACCCAGCCCCATGCCTGTCAGCCCTGAGTGTCTGGAGACCCTCCAAGGAGATGAGAGGGTCCTCTCCATCCTT 346 
13 K V M K C V L E V I SDSLSKPSPMPVSP ECLETLQGDERVLSIL 52 
347 CGACACCAGAATTTGCTGAAGGAACTTCAAGACCTGGCGCTTCAAGGTGCCAAGGAGCGGGcccAGcAGcAGCAGcAGcAGcAGCAGCAGCAGcAGCAGCAGCAGCAGCAGC~CAAC~ 466 
53 R H QN L L K E LQ D L A L QG AK E R AQQQ QQ QQ QQQQQ QQ QQ QQ Q 92 
467 CAACACAGCAGCTTTGAGGATGAACTCTCGGAAGTATTTGAGAACCAGAGCCCTGCAGCCAAGCATGGAGACGCAGCATCAGAAGCCCCCTCC~GGACACTGTAGAGAAGAGAGAGGAT 586 
93 Q H S S FED E L S E V F E N Q S P A AK H G D A A S E A P S K D TV E K R E D 132 
I l 
587 TCTGACAAGGGGCAACAGGATGCCTTTGAGGG~CCACAGAAGGACCCAGACCTCAGGCCTTTCCAGAGCCCAAGCAGGAGTCCTCTATGATGGGAAACAGTCAATCTCCAGGGGAGGAC 706 
133 SDKGQQDAFEGTTEGPRPQAFPEPKQESSMMGNSQSPGED 172 
701 ACAGCCAACAATACCCAATCACCAACCAGCCTCCCCAGCCAGGAGCATGGGATTCCACAGACCACAGAAGGCAGTGAGAGAGGTCCCAGTGCCCAGCAGCAAGCCAGAAAAGCCAAGC~ 826 
173 TAN N T Q S P T S L P SQEHGIPQTTEGSERGPSAQQQARKAKQ 212 
* 1 
827 GAGGAGAAAGAGGAAGAGGAGGAGGAGAAAGAGGAAGAGGAGGAGGAGAAAGAGGAGAAGGCGATCGCCAGAGAG~GGCTGGGCCT~AGAAGTCCCCACGGCAGCATCCAGTTCTCAC 946 
213 E E K E E E E E E K E E EEEEKEEKAIAREKAGPKEVPTAAS s s H 252 
947 TTCTATTCAGGCTACAAGAAGATCCAGAAAGATGATGATGGTCAGTCGGAGTCTCAG~AGTG~TGGA~GACAGGGGCTTCTGAAGCTGTGCCATCTG~GGGAAGGGGGAGCTGGAG 1066 
253 F Y SG Y K K I QK D D DG Q S ES QAVN G K T G A S E A V P S E G KG E I, E 292 
+ f 
1067 CACTCTCAGCAGGAGGAAGATGGGGAAGAGGCCATGGCAGGGCCCCCCCAAGGTCTCTTCCCAGGTGGG~GGGCCAGGAGCTGGAACGTAAGCAGCAGGAGGAGG~GAGG~GAGGAG 1186 
293 H 5 Q Q E E D G E E AM A G P P Q G L F P G G K G Q E L E R K Q Q E E E E E E E 332 
f t 
1187 CGTCTGTCCAGAGAATGGGAGGACAAGCGATGGAGCAGGATGGACCAGCTGGCCAAGGAGCTGACAGCAGAGAAGCGGCTGGAGGGGGAAGATGACCCTGACCGGTCCATGAAGCTCTCC 1306
333 R L S R EWE D K R W S R M D Q L A K E L T A E K R L E GE D D P D R S M K L s 372 
(I. f. 
1307 TTCCGGGCCCGGGCCTATGGTTCAGGGACCCTGGGCCTCAGCTACGCCGGGGCTGGAGGCCATCTTCCAGAGAAGACAGTGTGGAGGCCCGAGGCGACTTTGAGG~AAGAAGGAAGAG 1426 
373 F R A RA YG F RD P G P Q L R RG W R P S S R E D S V E A R G D FEEKKEE 412 
l l * * 
1427 GAGGGCAGCGCCAACCGCAGAGCAGAGGACCAGGAGCTAGAGAGCCTGTCAGCCATCGAGGCAGAGCTGGAGAAGGTGGCCCACCAGCTGCAGGCTTTGCGACGGGGATGAGGCACTGGC 1546 
413 E G SAN R RA E D Q E L E S L SA I E A E LE KVA H Q L QA LR R G l 448 
I f .f 
1547 TGGTGGGGTC CGGCCATGGC TTCAAGGCCC AACTGCTGCT CAAGTAGGGA GGCTTCCAGC CTCAGAGCCC AGGTTACCCC TTGCCCCTTC CCTTCTCTTG CTCTCAGCCC 1656 
1657 CTGCCCTGGA CACTTCTGCA GGGCAGCCCT GAAAGTCAAC ACAGATTCTT TCTCGGAACA CAGGCAGCTT TCTAGAAGTT TCTCTTCCAC CTTCTAATCC ATGGGGCACA 1766 
1167 ACTGCAGTAG TTCTGATCTT TGGGCGAAAG CCGAGAACTC CTGACTATTA AGATATTCCA GATAAAATTT ATTGAAGGAA GAATAAACCT GCTTTCGGGC TCTTC 1871 
Fig.2. Primary structure of rat prechromogranin A mRNA. Negative numbers below the amino acid sequence indicate signal peptide. 
Numbers at the beginning and end of each sequence line refer to nucleotide and amino acid residues. Paired asterisks indicate dibasic 
amino acids. The underlined areas are: the N-terminus of rat chromogranin A l-14 identical to that reported for ,&granin [21], the 
region (residues 264-314) homologous to porcine pancreastatin, and the WE-14 region (residues 343-356). 
peptide in rat, if indeed chromogranin A is its pro- 
hormone, must await processing studies employing 
rat-specific antibodies. 
A peptide homologous to the N-terminus of 
bovine chromogranin A has been purified and se- 
quenced from an insulinoma passaged in rats [2 11. 
The N-terminus of this peptide, called ,&-granin, is 
identical to the sequence of rat chromogranin A 
[21]. Since P-granin is identical in known sequence 
to rat chromogranin A (fig.2), chromogranin A is 
probably the precursor for P-granin, as suggested 
by Hutton and co-workers [22,23] based on pulse- 
chase experiments in insulinoma tissue, 
demonstrating that ,&granin derives from a 
chromogranin A-immunoreactive precursor. Rat 
chromogranin A 1-128 is most likely the primary 
structure of ,6-granin, since this fragment precedes 
a conserved KR processing sequence (fig.2). Hut- 
ton and co-workers have already postulated that a 
dibasic processing signal analogous to bovine 
chromogranin A KR1141115 is responsible for the 
generation of P-granin in pancreatic tissue [22,23]. 
They suggest that ,&granin is a terminally process- 
ed product of chromogranin A in insulinoma and 
117 
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Fig.3. Sequence of rat prechromogranin A depicted schematically, with homology to bovine chromogranin A shown below. Percent 
homology of the IS-amino-acid signal sequence, and successive lo-amino-acid lengths of rat chromogranin, to the sequence of bovine 
prechromogranin A was calculated. Whenever the bovine or rat sequences were gapped to maximize alignment, the number of amino 
acids in the gap, and the species of the sequence gapped are indicated by a number and a letter R (rat) or B (bovine). Numbers in 
parentheses, followed by a B, indicate the number of residues in the corresponding region of the bovine sequence compared, when 
that number was not ten. Residues in the bovine sequence gapped were excluded from the homology calculation. Residues in the rat 
sequence gapped were included as ‘zero homology’ in the calculation of overall homology for the IO-amino-acid sequence. From left 
to right, diamond-patterned, signal sequence; dark-shaded, N-terminal sequence containing cysteine residues (C); checkered, 
polyglutaminyl sequence (Q.. . Q); hatched circles, potential glycosylation sites; hatched, polyglutamyl sequences; dotted, region 
homologous to porcine pancreastatin; light-shaded, peptide regions bounded by pairs of basic amino acids. Each peptide fragment 
is designated by the single-letter code for its N- and C-terminal amino acid residues, and the number of residues in the fragment. 
Positions of pairs of basic ammo acids are shown above; boxed pairs are conserved between rat and bovine sequences. The position 
of the sequence RDG is indicated, as are the repeated sequences LRRG. 
endocrine pancreas [22,23]. If so, patterns of 
chromogranin A processing are quite different in 
pancreas and adrenal medulla [24]. 
Chromogranin A immunoreactivity has been 
detected by histochemical and biochemical 
methods in bovine and rat endocrine tissues as well 
as in bovine brain [7-l 11. In rat and cow, it is pre- 
sent in adrenal medulla, pituitary, parathyroid, 
thyroid, endocrine gut and pancreas [7-l 11. A 
2.1 kb chromogranin A mRNA is present in 
anterior pituitary, abundant in adrenal medulla, 
and not detectable in adrenal cortex of rat (fig.4). 
In bovine brain, chromogranin A immunoreactivi- 
ty is found in cerebral cortex, hippocampus, 
amygdala, basal ganglia, and spinal cord by im- 
Fig.4. Distribution of chromogranin A mRNA in rat adrenal 
medulla (lane l), rat adrenal cortex (lane 2), and rat anterior 
pituitary (lane 3) by Northern blot hybridization with clone 
pCHRG2H. All lanes contain 1 Fg total RNA. Exposure was 
for 48 h. 
28s 
18s 
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munohistochemistry and radioimmunoassay [7,9]. 
Chromogranin A mRNA is detectable in bovine 
striatum [12]. In brain stem, chromogranin A im- 
munoreactivity is co-localized to the major 
catecholaminergic cell groups [9]. The im- 
munoreactivity was found mainly in the Golgi 
region of cells in these areas, although nerve ter- 
minals were stained in brain stem and spinal cord 
[9]. In the rat central nervous system (CNS), 
chromogranin A mRNA is detected in cerebral cor- 
tex and hippocampus (fig.5). The distribution of 
chromogranin A mRNA in the rat CNS is currently 
under investigation. Since chromogranin A im- 
munoreactivity in bovine brain is visible mainly in 
cell bodies [9], chromogranin A may be processed 
to smaller non-immunoreactive peptides in axons 
and nerve terminals. 
Several rat and mouse cell lines of neuroen- 
docrine origin express chromogranin A mRNA 
(fig.5). These include PC12 pheochromocytoma 
[25], AtT-20/D 16v- 16 pituitary adenoma [26], and 
RIN-m insulinoma [27]. Chromogranin A mRNA 
is also expressed abundantly in 5F and 14B cell 
lines (fig.5), subclones of RIN-m that secrete in- 
sulin and somatostatin [28]. The presence of 
chromogranin A mRNA in insulinoma cell lines 
further supports the suggestion of Hutton and co- 
workers that chromogranin A is the precursor of p- 
granin [22,23]. Insulinoma, pheochromocytoma 
and pituitary adenoma cells may be excellent 
models for studying tissue specificity of 
chromogranin processing and secretion. 
Fig.6 depicts chromogranin A mRNA in rat 
adrenal gland detected by in situ hybridization 
histochemistry. Messenger RNA expression is con- 
fined to the medulla, and is evenly distributed in it. 
/ 
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Fig.5. Northern blot analysis of chromogranin A mRNA in rat neuroendocrine tissues and tumor cell lines. RNA preparation and 
hybridization were performed as described in section 2. Positions of calf liver and E. coli ribosomal RNA markers are indicated. Rat 
adrenal medulla (l), rat cerebral cortex (2), rat hippocampus (3), SF, an insulin-secreting subclone of the RIN-m cell line (4), 14B, 
a subclone of RIN-m that secretes omatostatin (5), RIN-m, a rat insulinoma cell line (6), AtT-20/D16v-16, a mouse pituitary tumor 
cell line (7) RAT-2, a fibroblast line (8), PC12, a rat pheochromocytoma cell line (9), PC12 (lo), and rat hippocampus (11). All lanes 
contain 1 pg total RNA except for lane 2 which has 2.5 pg poly(A)+ RNA. Lanes l-9 are for a 12 h exposure. Lanes 10,ll are a 32 h 
exposure of lanes 3,9. 
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Fig.6. Localization of chromogranin A mRNA in the rat adrenal gland by in situ hybridization histochemistry. (A) Dark-field view 
showing heavy labeling in the medulla after hybridization with a complementary RNA probe (X 31). (B) Bright field view of 
chromogranin A mRNA positive cells in the medulla of the adrenal gland (X 500). 
In bovine adrenal gland, chromogranin A mRNA 
is more abundantly distributed in the outer 
medulla, similar to phenylethanolamine N- 
methyltransferase (PNMT) mRNA (Siegel, R.E. et 
al., unpublished). Sietzen et al. have recently noted 
that chromogranin A in rat adrenal medulla, like 
PNMT, is decreased by hypophysectomy and 
restored by treatment with dexamethasone [29,30]. 
Chromogranin A mRNA in rat adrenal medulla is 
also decreased by hypophysectomy, demonstrating 
glucocorticoid regulation of chromogranin expres- 
sion at a pretranslation locus (Fischer-Colbrie, R. 
120 
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et al., unpublished). In cultured PC12 cells, 
chromogranin A mRNA is increased significantly 
in response to dexamethasone (Rausch, D. and 
Eiden, L.E., unpublished). Thus, the distribution 
of both chromogranin A and PNMT in rat and 
bovine adrenal medulla may be a function of dif- 
ferent amounts of glucocorticoids, or differential 
sensitivity to glucocorticoid stimulation, from the 
outer to the inner portions of the gland. 
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